Helmholtz Munich

#LeibnizPrize 2025: Celebrating Excellence! 🎉 👏 Yesterday, Prof. Maria-Elena Torres-Padilla officially received the Gottfried Wilhelm Leibniz Prize from the Deutsche Forschungsgemeinschaft (DFG) - German Research Foundation (#DFG)! She was recognized for her pioneering research on epigenetic plasticity and stem cell reprogramming in early mammalian development. 🌟 Her work explores epigenetic reprogramming and how chromatin structure regulates cellular adaptability. 🌟 A key milestone was identifying epigenetic factors that drive the first step of reprogramming – from the totipotent stem cells to differentiated cells. At #HelmholtzMunich, Maria-Elena Torres-Padilla is the Head of the Stem Cell Center (rotating) and the Director of the Institute of Epigenetics and Stem Cells, as well as Director of Biomedicine at the Helmholtz Pioneer Campus. 👏 Congratulations Maria-Elena to Germany's highest scientific honor! 🎉 👉 Learn more in our news: https://lnkd.in/e5u3QySd 🎥Watch the portrait of Prof. Maria-Elena Torres-Padilla: https://lnkd.in/gFwSX-jb Epigenetics Research at Helmholtz Munich Helmholtz PioneerCampus @ Helmholtz Munich Ludwig-Maximilians-Universität München Nationale Akademie der Wissenschaften Leopoldina Latin American Studies Association (LASA) EMBO EMBL #Epigenetics #StemCells #Award #Research #ResearchPioneers #LeibnizPreis #Wissenschaftspreis #reprogramming

Using AI to Decipher the Mechanisms of Cancer Metastasis 🚀 #HelmholtzMunich is excited to be part of DECIPHER-M, a collaborative project of leading research institutions using #AI to better understand #cancer cell spread. 🔬What is DECIPHER-M? This project aims to develop a multimodal foundation model to improve cancer diagnoses and enable personalized treatment options for patients. 💡Led by Prof. Julia Schnabel, the team at Helmholtz Munich will develop the #FoundationModel, integrating data from pathology, radiology, text reports, and electronic health records to enhance the prediction and understanding of cancer metastasis.   🌍 Funded by the German Federal Ministry of Education and Research (#BMBF), this three-year initiative brings together experts from medicine, computer science, and biotechnology, and has the potential to transform cancer care.   👉 Read more about the project: https://lnkd.in/gxbcin6b Julia A. Schnabel Bundesministerium für Bildung und Forschung Technische Universität Dresden Uniklinik RWTH Aachen Universitätsmedizin Essen Technische Universität München Universitätsmedizin Mainz DKFZ Deutsches Krebsforschungszentrum #CancerResearch #PrecisionMedicine #MachineLearning #Oncology #CancerCare

We're celebrating: This evening, Prof. Maria-Elena Torres-Padilla will be honored with the #LeibnizPrize! 🎉 Watch the ceremony live:  🗓️ Wednesday, March 19  ⏰ Live stream starts at 5pm ▶️ https://lnkd.in/etzepjjY Interested in learning more about Maria-Elena Torres-Padilla's research? 👉Check out her interview “Empowering Cells’ and Scientists’ Potential for Cell Therapies”:  https://lnkd.in/d4aMAzhX 👉Discover insights into embryonic development in our story:  https://lnkd.in/eXtqRfAA Epigenetics Research at Helmholtz Munich Deutsche Forschungsgemeinschaft (DFG) - German Research Foundation Helmholtz PioneerCampus @ Helmholtz Munich Helmholtz-Gemeinschaft Ludwig-Maximilians-Universität München Nationale Akademie der Wissenschaften Leopoldina Latin American Studies Association (LASA) EMBO EMBL #Epigenetics #StemCells #Award #Research #DFG #LeibnizPreis 

📢 New Publication:  "Quantitative characterization of cell niches in spatially resolved omics data", published in #NatureGenetics 👇 Check out more👇 Sebastian Birk Mo Lotfollahi Wellcome Sanger Institute Julius-Maximilians-Universität Würzburg Human Cell Atlas #HelmholtzMunich

🔬 March is Autoimmune Disease Awareness Month! 🧬   Autoimmune diseases, like type 1 diabetes, affect millions worldwide. At Helmholtz Munich, we’re dedicated to advancing research and prevention.   The Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) identifies newborns with an increased genetic risk of type 1 diabetes — a key step toward early prevention. GPPAD has also launched its official LinkedIn page, so be sure to follow them for the latest updates in #T1D prevention. Learn in their latest post, how you can participate in their research.   👉 Follow Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) and support the prevention of type 1 diabetes!   #AutoimmuneDiseaseAwareness #Type1Diabetes #HelmholtzMunich #GPPAD #NewbornScreening #Prevention #ResearchMatters

🚀 Exciting News: new Health Data Science & AI Certificate Program 🚀 Are you interested in the up-and-coming field of health data research? Are you studying or doing a PhD in a STEM subject? This new DZD program is designed for you! Our DZD HeaDS & AI program offers: 🔍 KNOWLEDGE in current AI methods 🌐 OVERVIEW of developments in health data science in Germany and the EU 🛠️ HANDS-ON Workshops | Hackathons | Excursions 🤝 CONTACTS with established scientists and motivated newcomers Program start is in spring 2026. Pre-register now and stay tuned on updates: Please share this information in your networks. #HealthDataScience #AI #CertificateProgram #DZD #Research #STEM

KORA Study – 40 Years of Advancing Public Health Research🎉 🌟 This year marks the 40th anniversary of the KORA study (Cooperative Health Research in the Region of Augsburg) – one of Germany’s most impactful population-based research initiatives. 💡Since its launch in 1984 as part of the WHO MONICA project, KORA has tracked around 18,000 participants, generating key insights into #CardiovascularDisease, #Type2Diabetes, #LungDisease, and #MentalHealth disorders. 🗨️ “KORA is a flagship study that continues to shape public health policies and improve disease prevention.”  Prof. Annette Peters, Director of the Institute of Epidemiology, #HelmholtzMunich  Learn how #KORA is improving #health by:    🌟Shaping health guidelines on air pollution    🌟Researching the impact of temperature extremes on chronic diseases   🌟Driving prevention insights in diabetes and obesity   🌟Innovating personalized digital health solutions    🔗 Learn more in our news: https://lnkd.in/d9ixiKx8   👉Read the #interview with Prof. Annette Peters "Long-Term Health Studies Show Effects of Heat with Evidence":  https://lnkd.in/daSaEm9k 👉 Read Dr. Alexandra Schneider’s interview “Heavy Rain, Heat, and Cold Stress Health”:   https://lnkd.in/dN-K7kzV 👉Read the interview with Dr. med. habil. Katharina Lechner, Medical Lead of the KORA Digital-Fit Intervention Study about Personalized Digital Health:  https://lnkd.in/gEVPDyYG Epidemiology at Helmholtz Munich Birgit Linkohr #PublicHealth #Epidemiology #AirPollution #DiabetesPrevention #ClimateHealth #KORAStudy #Diabetes #Biorepository #Anniversary #Jubilee #Augsburg 

New Benchmarks in Airway Function and Disease Modeling 🫁 Dr. Janna Nawroth and her team at the Helmholtz PioneerCampus @ Helmholtz Munich have uncovered critical differences between human and rodent airways, reshaping respiratory research. 🔬By mapping mucociliary clearance (#MCC) and refining in vitro cultures, they’ve established new benchmarks for more accurate disease models. 💡Their work reveals key species-specific variations and highlights flaws in existing models, offering new pathways to improve treatments for diseases like #asthma, #COPD, and #cysticfibrosis. 👉 Read more: https://lnkd.in/dwADR6WS TUM Deutsches Zentrum für Lungenforschung (DZL) Amy Ryan Doris Roth Ayşe Tuğçe Şahin   #HelmholtzMunich #MucociliaryClearance #RespiratoryHealth #Biomechanics #Cilia #NatureCommunications #StructureFunction

Cell Fate Changes – How Transcriptional Memory Affects Reprogramming 🧬 A team led by Dr. Eva Hörmanseder and Dr. Antonio Scialdone, #HelmholtzMunich, has identified key factors that limit nuclear reprogramming – the process of transforming one cell type into another. 💡 While promising for regenerative medicine, reprogramming often leads to dysfunctional cells. Key Findings: 🌟Some cells retain a "memory" of their original identity, resisting transformation. 🌟Certain genes linked to the original cell type hinder reprogramming success. 🌟Suppressing these genes improves reprogramming efficiency and cell functionality. These insights could enhance cell-based therapies for conditions like organ failure and neurodegenerative diseases, and regenerative medicine. 👉 Learn more: https://lnkd.in/dkc3RcPR   Epigenetics Research at Helmholtz Munich #CellReprogramming #Epigenetics #StemCells #RegenerativeMedicine #NeurodegenerativeDiseases

🧬 Antigenic Variation: How Parasites Outsmart the Immune System 🦠 A new study by #HelmholtzMunich and Ludwig-Maximilians-Universität München reveals how Trypanosoma brucei, the parasite behind African sleeping sickness, changes its surface proteins to evade the immune system.   🔬 Using advanced single-cell RNA sequencing, researchers around Prof. Maria Colome Tatche and Prof. Nicolai Siegel tracked how the parasite switches its antigens, uncovering that #DNA repair mechanisms dictate which antigen appears next. 💡These findings could pave the way for new treatments – not just for T. brucei, but for other pathogens using similar survival tactics. 👉 Read more about the study: https://lnkd.in/df9xjKwZ   Nature Portfolio Epigenetics Research at Helmholtz Munich Biomedical Center Munich #AntigenicVariation #Immunology #Trypanosomes #TrypanosomaBrucei #Genomics #InfectiousDiseases #ImmuneSystem